Kevin Sheng‐Po Yuan

Medicine · Health Sciences

14h-index789citations24works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(8), Lung Cancer Diagnosis and Treatment(5), Lung Cancer Treatments and Mutations(4), Esophageal Cancer Research and Treatment(3), Salivary Gland Tumors Diagnosis and Treatment(3)

Publications24 total

Testing the Validity of Markov Chains in Analyzing Soccer Gameplay through Barcelona’s 2020-2021 La Liga Season
Journal of Student Research·2022Open Access
Complex Roots of Quadratics with the Floor Function
Journal of Student Research·2022· 1 citedOpen Access
Assessment of Predictive Scoring System for 90-Day Mortality Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Completed Concurrent Chemoradiotherapy
JAMA Network Open·2020· 49 citedOpen Access
Outcomes of Adjuvant Oral versus Intravenous Fluoropyrimidines for High-Risk Stage II or Stage III Colon Adenocarcinoma: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study
Journal of Cancer·2020· 2 citedOpen Access
Adjuvant Therapy for High-Risk Stage II or III Colon Adenocarcinoma: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study
Cancers·2019· 14 citedOpen Access
Toxicity Profiles of Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenomas
Cancers·2019· 10 citedOpen Access
Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell Carcinoma
Cancers·2019· 15 citedOpen Access
Risk of cardiotoxicity induced by adjuvant anthracycline-based chemotherapy and radiotherapy in young and old Asian women with breast cancer
Strahlentherapie und Onkologie·2019· 28 cited
Predicting 90-Day Mortality in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma after Curative Surgery
Cancers·2018· 23 citedOpen Access
Combination of recurrent oral aphthae and dry eye syndrome may constitute an independent risk factor for oral cavity cancer in elderly women
Cancer Management and Research·2018· 6 citedOpen Access
Intensity-modulated radiotherapy with systemic chemotherapy improves survival in patients with nonmetastatic unresectable pancreatic adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study
Radiotherapy and Oncology·2018· 21 cited
Recurrent aphthous stomatitis may be a precursor or risk factor for specific cancers: A case‐control frequency‐matched study
Cancer Medicine·2018· 7 citedOpen Access
Efficacy of thoracic radiotherapy in patients with stage IIIB–IV epidermal growth factor receptor-mutant lung adenocarcinomas who received and responded to tyrosine kinase inhibitor treatment
Radiotherapy and Oncology·2018· 40 cited
Treatment of advanced nasopharyngeal cancer using low- or high-dose concurrent chemoradiotherapy with intensity-modulated radiotherapy: A propensity score-matched, nationwide, population-based cohort study
Radiotherapy and Oncology·2017· 33 cited
Dose escalation intensity-modulated radiotherapy–based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma
Radiotherapy and Oncology·2017· 103 cited
High‐dose or low‐dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer
Head & Neck·2017· 37 cited
Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes
Oncotarget·2017· 203 citedOpen Access
Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity‐modulated radiation therapy techniques
Cancer·2017· 68 citedOpen Access
Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma
Cancer Medicine·2016· 31 citedOpen Access
Efficacy of postoperative radiotherapy in patients with pathological stage N2 epidermal growth factor receptor wild type adenocarcinoma and squamous cell carcinoma lung cancer
Oncotarget·2016· 7 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Szu‐Yuan Wu(19), Alexander T.H. Wu(16), Chia-Lun Chang(9), Jer‐Hwa Chang(5), Kuan‐Chou Lin(5), Wei-Cheng Lin(4), Han-Lin Hsu(4), Jyh-Ming Chow(4), Tsung-Ming Chen(4), Lei Qin(4), Chia‐Lun Chang(3), Ben‐Chang Shia(3), Yu‐Chun Yen(2), Yu‐Chun Yen(2), Tsung‐Ming Chen(2), Yi‐Wei Kao(2), Yen‐Kuang Lin(2), Bou‐Yue Peng(2), Chia‐Che Wu(1), Hsieh‐Chih Tsai(1)